Truvestments Capital’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.96K | Hold |
109
| – | – | ﹤0.01% | 761 |
|
|
2025
Q1 | $3.95K | Hold |
109
| – | – | ﹤0.01% | 779 |
|
|
2024
Q4 | $4.59K | Hold |
109
| – | – | ﹤0.01% | 711 |
|
|
2024
Q3 | $6.06K | Buy |
+109
| New | +$6.06K | ﹤0.01% | 658 |
|
|
2024
Q2 | – | Sell |
-158
| Closed | -$7.38K | – | 572 |
|
|
2024
Q1 | $7.38K | Hold |
158
| – | – | ﹤0.01% | 519 |
|
|
2023
Q4 | $7.56K | Hold |
158
| – | – | ﹤0.01% | 540 |
|
|
2023
Q3 | $5.63K | Hold |
158
| – | – | ﹤0.01% | 502 |
|
|
2023
Q2 | $7.29K | Hold |
158
| – | – | ﹤0.01% | 487 |
|
|
2023
Q1 | $6.34K | Buy |
158
+87
| +123% | +$3.49K | ﹤0.01% | 481 |
|
|
2022
Q4 | $3.29K | Hold |
71
| – | – | ﹤0.01% | 626 |
|
|
2022
Q3 | $3K | Hold |
71
| – | – | ﹤0.01% | 522 |
|
|
2022
Q2 | $4K | Buy |
+71
| New | +$4K | ﹤0.01% | 507 |
|
|
2022
Q1 | – | Sell |
-37
| Closed | -$3K | – | 454 |
|
|
2021
Q4 | $3K | Hold |
37
| – | – | ﹤0.01% | 531 |
|
|
2021
Q3 | $3K | Hold |
37
| – | – | ﹤0.01% | 511 |
|
|
2021
Q2 | $4K | Hold |
37
| – | – | ﹤0.01% | 489 |
|
|
2021
Q1 | $4K | Sell |
37
-11
| -23% | -$1.19K | ﹤0.01% | 545 |
|
|
2020
Q4 | $6K | Buy |
+48
| New | +$6K | ﹤0.01% | 480 |
|
|
2019
Q4 | – | Sell |
-85
| Closed | -$4K | – | 472 |
|
|
2019
Q3 | $4K | Sell |
85
-9
| -10% | -$424 | ﹤0.01% | 606 |
|
|
2019
Q2 | $6K | Hold |
94
| – | – | ﹤0.01% | 599 |
|
|
2019
Q1 | $7K | Buy |
+94
| New | +$7K | 0.01% | 565 |
|
|
2018
Q3 | $7K | Buy |
+97
| New | +$7K | ﹤0.01% | 706 |
|